Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 11 studies | 26% ± 9% | |
non-classical monocyte | 6 studies | 25% ± 7% | |
macrophage | 6 studies | 20% ± 5% | |
monocyte | 5 studies | 21% ± 3% | |
myeloid cell | 3 studies | 20% ± 3% |
Insufficient scRNA-seq data for expression of NFAM1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 1776.46 | 578 / 578 | 87% | 8.05 | 1008 / 1155 |
breast | 83% | 319.88 | 382 / 459 | 91% | 7.54 | 1022 / 1118 |
thymus | 72% | 204.76 | 472 / 653 | 95% | 8.51 | 577 / 605 |
kidney | 79% | 315.16 | 70 / 89 | 88% | 8.04 | 790 / 901 |
intestine | 81% | 345.62 | 779 / 966 | 74% | 4.56 | 391 / 527 |
adrenal gland | 96% | 527.03 | 248 / 258 | 52% | 2.87 | 119 / 230 |
bladder | 86% | 231.00 | 18 / 21 | 59% | 4.05 | 297 / 504 |
prostate | 84% | 274.76 | 205 / 245 | 57% | 2.04 | 287 / 502 |
uterus | 59% | 156.59 | 101 / 170 | 77% | 4.86 | 353 / 459 |
stomach | 55% | 180.50 | 198 / 359 | 79% | 5.06 | 227 / 286 |
brain | 45% | 129.68 | 1192 / 2642 | 88% | 7.25 | 621 / 705 |
skin | 55% | 140.24 | 991 / 1809 | 78% | 7.15 | 367 / 472 |
esophagus | 66% | 187.52 | 954 / 1445 | 66% | 3.39 | 121 / 183 |
pancreas | 42% | 124.60 | 138 / 328 | 88% | 7.98 | 156 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 35.13 | 29 / 29 |
spleen | 100% | 5549.29 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 26631.33 | 918 / 929 | 0% | 0 | 0 / 0 |
adipose | 96% | 813.26 | 1158 / 1204 | 0% | 0 | 0 / 0 |
liver | 57% | 230.69 | 128 / 226 | 38% | 1.90 | 153 / 406 |
tonsil | 0% | 0 | 0 / 0 | 91% | 10.21 | 41 / 45 |
ovary | 27% | 67.18 | 48 / 180 | 64% | 3.57 | 275 / 430 |
blood vessel | 61% | 275.39 | 819 / 1335 | 0% | 0 | 0 / 0 |
heart | 58% | 187.79 | 501 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 38% | 1.58 | 30 / 80 |
muscle | 4% | 6.54 | 31 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045577 | Biological process | regulation of B cell differentiation |
GO_0007165 | Biological process | signal transduction |
GO_0050853 | Biological process | B cell receptor signaling pathway |
GO_0033173 | Biological process | calcineurin-NFAT signaling cascade |
GO_0050861 | Biological process | positive regulation of B cell receptor signaling pathway |
GO_0001819 | Biological process | positive regulation of cytokine production |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0006954 | Biological process | inflammatory response |
GO_0030183 | Biological process | B cell differentiation |
GO_0045121 | Cellular component | membrane raft |
GO_0035577 | Cellular component | azurophil granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | NFAM1 |
Protein name | NFAT activation molecule 1 (Calcineurin/NFAT-activating ITAM-containing protein) (NFAT-activating protein with ITAM motif 1) |
Synonyms | CNAIP |
Description | FUNCTION: May function in immune system as a receptor which activates via the calcineurin/NFAT-signaling pathway the downstream cytokine gene promoters. Activates the transcription of IL-13 and TNF-alpha promoters. May be involved in the regulation of B-cell, but not T-cell, development. Overexpression activates downstream effectors without ligand binding or antibody cross-linking. . |
Accessions | ENST00000329021.10 Q8NET5 |